The purpose of this study is to determine the effects of change in diet quality (carbohydrate restriction versus fat restriction) on body composition, fat distribution, cardiometabolic risk factors, physical function, and quality of life in aging adults with obesity.
The purpose of this study is to determine the effects of change in diet quality (carbohydrate restriction versus fat restriction) on body composition, fat distribution, cardiometabolic risk factors, physical function, and quality of life in aging adults with obesity. Data from previous studies support the hypothesis that consumption of lower-CHO, higher-fat food sources rich in high-quality proteins and essential fatty acids, such as whole eggs, has beneficial effects on metabolic health. The study will test the hypothesis that a reduced CHO higher- fat, egg-rich diet induces selective depletion of total and abdominal adiposity, preserves lean mass, and reduces inflammation and oxidative stress. In turn, these favorable changes in body composition, fat distribution, and metabolic health will confer improvements in physical function in obese, aging adults. Results from this study will form an empirical basis for developing an easily implemented, non-pharmacologic treatment (i.e. change diet quality by incorporating more low carbohydrate, whole foods such as eggs) to prevent or reverse sarcopenia and other age-related diseases of metabolic origins.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
34
Participants will be asked to consume a carbohydrate-restricted diet including whole eggs for 8 weeks. Eggs will be provided.
Participants will be asked to consume a low fat, carbohydrate-based diet for 8 weeks. Breakfast food items will be provided.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Changes in total fat mass as measured by dual-energy X-ray absorptiometry (DXA)
Time frame: 8 weeks after baseline
Changes in visceral adipose tissue as measured by magnetic resonance imaging (MRI)
Time frame: 8 weeks after baseline
Changes in total lean mass as measured by DXA
Time frame: 8 weeks after baseline
Changes in subcutaneous abdominal adipose tissue as measured by MRI
Time frame: 8 weeks after baseline
Changes in thigh intermuscular adipose tissue as measured by MRI
Time frame: 8 weeks after baseline
Changes in thigh skeletal muscle volume as measured by MRI
Time frame: 8 weeks after baseline
Changes in thigh subcutaneous adipose tissue as measured by MRI
Time frame: 8 weeks after baseline
Changes in pro-inflammatory markers, Interleukin (IL)-6
Time frame: 8 weeks after baseline
Changes in pro-inflammatory marker, hsCRP
Time frame: 8 weeks after baseline
Changes in pro-inflammatory marker, Tumor Necrosis Factor (TNF)-α
Time frame: 8 weeks after baseline
Changes in metabolic hormone adiponectin
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 8 weeks after baseline
Changes in metabolic hormone leptin
Time frame: 8 weeks after baseline
Changes in metabolic hormone insulin
Time frame: 8 weeks after baseline
Changes in markers of oxidative stress : isoprostanes
Time frame: 8 weeks after baseline
Changes in markers of oxidative stress : protein carbonyls
Time frame: 8 weeks after baseline
Changes in markers of oxidative stress : total anti-oxidants
Time frame: 8 weeks after baseline
Changes in insulin sensitivity with euglycemic-hyperinsulinemic clamp
Time frame: 8 weeks after baseline
Changes in the lipid profile: triglycerides
Time frame: 8 weeks after baseline
Changes in the lipid profile: total cholesterol
Time frame: 8 weeks after baseline
Changes in the lipid profile: HDL-C
Time frame: 8 weeks after baseline
Changes in the lipid profile: LDL
Time frame: 8 weeks after baseline
Changes in physical function: Short Physical Performance Battery
Time frame: 8 weeks after baseline
Changes in physical function : muscle strength
Time frame: 8 weeks after baseline
Changes in quality of life (SF-36 Health Survey).
Time frame: 8 weeks after baseline